Clinical Trial Update: To Evaluate the Bioavailability of a Tablet of AZD1656 [Phase 1]

View source ↗

Summary

A Phase 1 study completed to evaluate the bioavailability of a tablet form of AZD1656 in Type 1 diabetes mellitus patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• AZD1656

Snippet

Sponsor: AstraZeneca | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED